AN OVERVIEW ON SCREENING FOR BREAST CANCER AWARENESS IN ROMANIAN GENERAL POPULATION

Authors

  • Alina MANOLE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Liliana CHELARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • I. GARDIKIOTIS Advanced Research and Development Center in Experimental Medicine (CEMEX) Iasi
  • M. MANOLE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • B. MONAC “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Georgiana FRUNZUC “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ioana Cristina AMIHAESEI “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Natalia VELENCIUC “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Madalina CIUHODARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Keywords:

BREAST CANCER, SCREENING, PREVENTION, QUALITY OF LIFE, QUESTIONNAIRE

Abstract

Trends in breast cancer incidence has been decreasing worldwide since several years, meanwhile screening programs were properly implemented in countries with financial support for healthcare infrastructure and population awareness to choose prevention. The study aim was to evaluate the level of knowledge regarding risk factors and screening for breast cancer in general population from Romania. Material and methods: The study was conducted on a group of 470 individuals aged between 21 and 55, during 1st October and 31st November 2016. The study was based on fulfilling an online questionnaire of 20 items, sent by e-mail. Results: Participants chose “breastfeeding” as a protective factor (84.47%), “family history” as a risk factor (78.09%), lobular carcinoma in situ as precancerous lesion (20.00%), mammography as a screening method (94.04%), performed “once a year in 45-54 aged women” (90.21%). A breast screening program would be useful in Romania because of the “high incidence” (98.30%) for “early detection of the disease” (97.87%), and nothing could deter people from screening participation (84.34%), but “fear of detecting a cancer” (12.64%). Conclusions: A larger study on a representative population group would provide better information and could be a capable guidance for national strategies on breast cancer prevention and screening.

Author Biographies

  • Alina MANOLE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • Liliana CHELARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Morphological Sciences (I)

  • M. MANOLE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • B. MONAC, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • Georgiana FRUNZUC, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • Ioana Cristina AMIHAESEI, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Morphological Sciences (I)

  • Natalia VELENCIUC, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Surgery (I)

  • Madalina CIUHODARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Mother and Child Medicine

References

1. Tendon A, Murray CJL, Lauer JA, Evans DB. Measuring overall health system performance for 191 countries. GPE Discussion Paper Series: No. 30, 2000.
2. Barber RM, et al. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet 2017; 390: 231-266.
3. Global Health Data Exchange. Global Burden of Disease Study 2015 (GBD 2015) Data Resources. Available online: http://ghdx.healthdata.org/gbd-2015 [Accessed on: 31.08.2017].
4. Socolov D, Anghelache I, Ilea C, Socolov R, Carauleanu A. Benign breast disease and the risk of breast cancer in the next 15 years. Rev Med Chir Soc Med Nat Iasi 2015; 119(1): 135-140.
5. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49(6): 1374-1403.
6. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (eds). Cancer Incidence in Five Continents, Vol. X (electronic version) Lyon, IARC, 2013. http://ci5.iarc.fr.
7. Oberaigner W, Daniaux M, Geiger-Gritsch S, Knapp R, Siebert U, Buchberger W. Introduction of organised mammography screening in Tyrol: results following first year of complete rollout. BMC Public Health 2011; 11: 673.
8. Vutuc C, Waldhoer T, Haidinger G. Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden. Eur J Cancer Prev 2006; 15: 343-346.
9. Altobelli E, Lattanzi A. Breast cancer in European Union: An update of screening programs as of March 2014 (Review). Int J Oncol. 2014; 45(5): 1785-1792.
10. ***Oncologic Regional Institute Iasi. Screening for breast cancer [Article in Romanian]. http://iroiasi.ro/web/portal-medical/programe-screening-san [Accessed on 31.08.2017].
11. Paap E, Holland R, den Heeten GJ et al. A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control 2010; 21:1569–1573.
12. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 108: 2205-2240.
13. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Over diagnosis of invasive breast cancer due to mammography screening. Ann Intern Med 2012; 157(3): 221-222.
14. Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst 2011; 103(24): 1821-1826.
15. Jecan RC, Hernic DA, Filip CI, Răducu L. Clinical data related to breast reconstruction; looking back on the 21th century and forward to the next steps. J Mind Medical Sci 2015; 2(1): 5.
16. Gardikiotis I, Azoicai D, Dobreanu C, Petrescu I, Lazar A, Manole A, Ghetu N. Socio-epidemiological points of view regarding quality of life in patients with and without breast reconstruction after mastectomy for cancer. Rev Res Soc Interv 2015; 52: 92-104.

Additional Files

Published

2017-09-30

Issue

Section

PREVENTIVE MEDICINE - LABORATORY